4//SEC Filing
Kinnevik AB (publ) 4
Accession 0001213900-19-014212
CIK 0001639225other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 5:00 PM ET
Size
27.3 KB
Accession
0001213900-19-014212
Insider Transaction Report
Form 4
Kinnevik AB (publ)
10% Owner
Transactions
- Conversion
Common stock, $0.001 par value per share
2019-07-29+18,771→ 1,699,974 total(indirect: See footnote) - Conversion
Common stock, $0.001 par value per share
2019-07-29+11,268→ 1,711,242 total(indirect: See footnote) - Conversion
Series A convertible preferred stock
2019-07-29−18,771→ 0 total(indirect: See footnote)→ Common stock, $0.001 par value per share (18,771 underlying) - Conversion
Common stock, $0.001 par value per share
2019-07-29+2,816,790→ 4,528,032 total(indirect: See footnote) - Purchase
Common stock, $0.001 par value per share
2019-07-29$28.00/sh+150,000$4,200,000→ 12,653,927 total(indirect: See footnote) - Conversion
Series C convertible preferred stock
2019-07-29−11,268→ 0 total(indirect: See footnote)→ Common stock, $0.001 par value per share (11,268 underlying) - Conversion
Series E convertible preferred stock
2019-07-29−4,984,100→ 0 total(indirect: See footnote)→ Common stock, $0.001 par value per share (4,984,100 underlying) - Conversion
Common stock, $0.001 par value per share
2019-07-29+4,984,100→ 9,512,132 total(indirect: See footnote) - Purchase
Common stock, $0.001 par value per share
2019-07-29$28.00/sh+2,991,795$83,770,260→ 12,503,927 total(indirect: See footnote) - Conversion
Series D convertible preferred stock
2019-07-29−2,816,790→ 0 total(indirect: See footnote)→ Common stock, $0.001 par value per share (2,816,790 underlying)
Kinnevik Online AB
10% Owner
Transactions
- Conversion
Common stock, $0.001 par value per share
2019-07-29+18,771→ 1,699,974 total(indirect: See footnote) - Conversion
Common stock, $0.001 par value per share
2019-07-29+11,268→ 1,711,242 total(indirect: See footnote) - Conversion
Series A convertible preferred stock
2019-07-29−18,771→ 0 total(indirect: See footnote)→ Common stock, $0.001 par value per share (18,771 underlying) - Conversion
Series D convertible preferred stock
2019-07-29−2,816,790→ 0 total(indirect: See footnote)→ Common stock, $0.001 par value per share (2,816,790 underlying) - Conversion
Series E convertible preferred stock
2019-07-29−4,984,100→ 0 total(indirect: See footnote)→ Common stock, $0.001 par value per share (4,984,100 underlying) - Conversion
Common stock, $0.001 par value per share
2019-07-29+2,816,790→ 4,528,032 total(indirect: See footnote) - Conversion
Common stock, $0.001 par value per share
2019-07-29+4,984,100→ 9,512,132 total(indirect: See footnote) - Purchase
Common stock, $0.001 par value per share
2019-07-29$28.00/sh+2,991,795$83,770,260→ 12,503,927 total(indirect: See footnote) - Purchase
Common stock, $0.001 par value per share
2019-07-29$28.00/sh+150,000$4,200,000→ 12,653,927 total(indirect: See footnote) - Conversion
Series C convertible preferred stock
2019-07-29−11,268→ 0 total(indirect: See footnote)→ Common stock, $0.001 par value per share (11,268 underlying)
Footnotes (8)
- [F1]Each share of Series A convertible preferred stock automatically converted into the Issuer's common stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering (the "IPO"), which closed on July 29, 2019, for no additional consideration. The shares had no expiration date.
- [F2]The shares of common stock are directly beneficially owned by Kinnevik Online AB ("Kinnevik Online"). Kinnevik AB (publ), as the sole shareholder of Kinnevik Online, may be deemed to have shared voting and dispositive power, and therefore, beneficial ownership, over the shares of common stock owned directly by Kinnevik Online.
- [F3]Each share of Series C convertible preferred stock automatically converted into the Issuer's common stock on a 1:1 basis immediately prior to the closing of the Issuer's IPO, which closed on July 29, 2019, for no additional consideration. The shares had no expiration date.
- [F4]Each share of Series D convertible preferred stock automatically converted into the Issuer's common stock on a 1:1 basis immediately prior to the closing of the Issuer's IPO, which closed on July 29, 2019, for no additional consideration. The shares had no expiration date.
- [F5]Each share of Series E convertible preferred stock automatically converted into the Issuer's common stock on a 1:1 basis immediately prior to the closing of the Issuer's IPO, which closed on July 29, 2019, for no additional consideration. The shares had no expiration date.
- [F6]The shares of Series A convertible preferred stock, Series C convertible preferred stock, Series D convertible preferred stock and Series E convertible preferred stock (collectively, the "Preferred Stock") were directly beneficially owned by Kinnevik Online. Kinnevik AB (publ), as the sole shareholder of Kinnevik Online, was deemed to have shared voting and dispositive power, and therefore, beneficial ownership, over the shares of Preferred Stock owned directly by Kinnevik Online.
- [F7]Concurrently with the IPO, on July 29, 2019, pursuant to a stock transfer agreement with Merck Global Health Innovation Fund, LLC ("Merck") and other parties thereto, dated July 15, 2019, Kinnevik Online purchased from Merck 2,991,795 shares of common stock in a secondary private placement at the IPO price of $28.00 per share.
- [F8]In connection with the Issuer's IPO, on July 29, 2019, Kinnevik Online purchased an aggregate of 150,000 shares of common stock at the IPO price of $28.00 per share.
Documents
Issuer
Livongo Health, Inc.
CIK 0001639225
Entity typeother
IncorporatedSweden
Related Parties
1- filerCIK 0001766574
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 5:00 PM ET
- Size
- 27.3 KB